Clinical Trial Update: LDN and tDCS in Fibromyalgia [Phase 2, Phase 3]

View source ↗

Summary

A completed clinical trial update involving LDN and tDCS in fibromyalgia across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• LDN (low-dose naltrexone)
• tDCS (transcranial direct current stimulation)

Snippet

Sponsor: Centro Universitario La Salle | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED